Coverage of doses of the HPV vaccine and variation by level of material deprivation in brazilian municipalities, 2012 to 2018
DOI:
https://doi.org/10.33448/rsd-v11i13.35484Keywords:
Papillomavirus; Vaccines; Adolescent.Abstract
Vaccination against HPV is an important prevention strategy that can reduce the burden of disease and the incidence of cancers in the long term. Therefore, this study aimed to characterize the temporal trend of HPV vaccine dose coverage and the variation in the level of material deprivation of Brazilian municipalities between 2012 and 2018. This is a longitudinal observational quantitative study that combined analysis of several observation units with a temporal trend design, which used data from the Sistema de Informação de Agravos de Notificação (SINAN). The frequencies of doses applied against the HPV vaccine were presented by year of analysis for the total population and stratified by sex. Municipalities were divided into quintiles according to the deprivation score of the Brazilian Deprivation Index. The frequencies of vaccine doses administered by deprivation quintiles were presented for the municipalities year by year. A total of 34,268,998 doses of HPV vaccine were applied in Brazil during the analyzed period, with higher doses during the national campaign period. Higher doses were observed among women compared to men (p=0.025). There was a trend of reduction in the number of doses over the years. Therefore, there is a need to develop measures to increase vaccination coverage against HPV, such as health education, sex education and public policies to reduce health and socioeconomic inequities.
References
Allik, M., Brown, D., Dundas, R., & Leyland, A. H. (2016). Developing a new small-area measure of deprivation using 2001 and 2011 census data from Scotland. Health & Place, 39, 122–130. https://doi.org/10.1016/J.HEALTHPLACE.2016.03.006
Almeida, M. de M., & Pereira, K. A. A. (2019). Educação e orientação sexual e prevenção das IST´S: ênfase para os riscos do papilomavírus humano (HPV). Anais Do XVI Congresso NUPIC. https://publicacoes.fafire.br/diretorio/nupic/nupic_2019_06.pdf
Alves, C. N. M., GUSMÃO, C. M. P., LINS, E. A., MOTA, L. D. M., ROCHA, N. M. da, & LISBÔA, G. L. P. (2020). Papilomavírus humano (HPV) e uso do preservativo: conhecimento de jovens brasileiros. Paper Knowledge . Toward a Media History of Documents, 12–26.
Brasil. (2018). Informe técnico da ampliação da oferta das vacinas papilomavírus humano 6, 11, 16 e 18 (recombinante) – vacina HPV quadrivalente e meningocócica C (conjugada). Ministério da saúde secretaria de vigilância em saúde departamento de vigilância das doenças transmissíveis coordenação-geral do programa nacional de imunizações.
Brown, D., Allik, M., Dundas, R., & Leyland, A. H. (2019). All-cause and cause-specific mortality in Scotland 1981–2011 by age, sex and deprivation: a population-based study. European Journal of Public Health, 29(4), 647–655. https://doi.org/10.1093/EURPUB/CKZ010
Brown, D., & Leyland, A. H. (2010). Scottish mortality rates 2000–2002 by deprivation and small area population mobility. Social Science & Medicine (1982), 71(11–3), 1951. https://doi.org/10.1016/J.SOCSCIMED.2010.09.015
Castellsagué, X., Muñoz, N., Pitisuttithum, P., Ferris, D., Monsonego, J., Ault, K., Luna, J., Myers, E., Mallary, S., Bautista, O. M., Bryan, J., Vuocolo, S., Haupt, R. M., & Saah, A. (2011). End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age. British Journal of Cancer, 105(1), 28. https://doi.org/10.1038/BJC.2011.185
Centro de Integração de Dados e Conhecimentos para Saúde. (2020). Fonte: Índice Brasileiro de Privação: https://cidacs.bahia.fiocruz.br/ibp
Darolt, J. B. (2019). Taxa de cobertura vacinal infantil brasileira.
Domingues CMAS, Teixeira AMS. (2013). Coberturas vacinais e doenças imunopreveníveis no Brasil no período 1982-2012: avanços e desafios do Programa Nacional de Imunizações. Epidemiol Serv Saude; 22(1):9-27 http://dx.doi.org/10.5123/S1679-49742013000100002
Dubé E, Vivion M, MacDonald NE. (2015). Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines. Jan;14(1):99-117. https://pubmed.ncbi.nlm.nih.gov/25373435/
Eluf, J. (2008). A vacina contra o papilomavírus humano Comentário sobre o artigo do Dr. In Rev Bras Epidemiol (Vol. 11, Issue 3).
Filho, N. de A., & Barreto, M. L. (2011). Epidemiologia e Saúde - Fundamentos, Métodos e Aplicações. | CECOVISA. Guanabara Koogan. http://www6.ensp.fiocruz.br/visa/?q=node/5744
Fiorati, R. C., Arcêncio, R. A., & Souza, L. B. D. (2016). Social inequalities and access to health: challenges for society and the nursing field. Revista Latino-Americana de Enfermagem, 24. www.eerp.usp.br/rlae
Fonsêca, E. de A. B. da, Oliveira, A. L. R. de, Dantas, R. K. N., & Salomão, M. A. A. de O. (2017). Adesão de Meninas à Campanha de Vacinação Contra HPV no Estado da Paraíba em 2014 (Vol. 15, Issue 1).
Hansen, P. R., Schmidtblaicher, M., & Brewer, N. T. (2020). Resilience of HPV vaccine uptake in Denmark: decline and recovery. Vaccine, 38(7), 1842-1848. https://doi.org/10.1016/j.vaccine.2019.12.019
MacDonald, N. E. (2015). SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 33(34): 4161-4. https://doi.org/10.1016/j.vaccine.2015.04.036
Magalhães, G. M., Vieira, É. C., Garcia, L. C., de Carvalho‐Leite, M. de L. R., Guedes, A. C. M., & Araújo, M. G. (2021). Atualização em papiloma vírus humano – Parte I: epidemiologia, patogênese e espectro clínico. Anais Brasileiros de Dermatologia, 96(1), 1–16. https://doi.org/10.1016/J.ABDP.2020.11.001
Melo, J. (2019). Vulnerabilidades de adolescentes masculinos ao HPV em instituições escolares do município de Parnaíba – PI - Dialnet. Revista Interdisciplinar, 12(1), 50–58. https://dialnet.unirioja.es/servlet/articulo?codigo=6966616
Moura, L. D. L., Codeço, C. T., & Luz, P. M. (2020). Human papillomavirus (HPV) vaccination coverage in Brazil: spatial and age cohort heterogeneity. Revista Brasileira de Epidemiologia, 24. https://doi.org/10.1590/1980-549720210001
Organização Mundial Saúde. (n.d.). (2021). Vacina contra o Vírus do Papiloma Humano (HPV) - OPAS/OMS | Organização Pan-Americana da Saúde. Organização Mundial Da Saúde. Retrieved October 6, from https://www.paho.org/pt/tag/vacina-contra-virus-do-papiloma-humano-hpv
Organização Pan-Americana da Saúde. (2019). Metodologia para o cálculo de cobertura da vacina contra o HPV na Região das Américas METODOLOGIA PARA O CÁLCULO. Organização Pan-Americana Da Saúde. www.paho.org
Organização Pan-Americana da Saúde. (n.d.). (2021). HPV e câncer do colo do útero - OPAS/OMS | Organização Pan-Americana da Saúde. Organização Pan-Americana Da Saúde. Retrieved October 6, from https://www.paho.org/pt/topicos/hpv-e-cancer-do-colo-do-utero
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM.
Queiroz, R. C. C. da S., Queiroz, R. C. de S., Rocha, T. A. H., Silva, F. de S., Santos, I. G. dos, Silva, I. P. da, Silva, N. C. da, Barbieri, M. A., Saraiva, M. da C. P., & Silva, A. A. M. da. (2021). Vaccination services and incomplete vaccine coverage for children: a comparative spatial analysis of the BRISA cohorts, São Luís (Maranhão State) and Ribeirão Preto (São Paulo State), Brazil. Cadernos de Saúde Pública, 37(6), e00037020. https://doi.org/10.1590/0102-311x00037020
Quevedo, J. P. de, Inácio, M., Wieczorkievicz, A. M., & Invernizzi, N. (2016). A política de vacinação contra o HPV no Brasil: a comunicação pública oficial e midiática face à emergência de controvérsias. Revista Tecnologia e Sociedade, 12(24), 1–26. https://doi.org/10.3895/RTS.V12N24.3206
Santos, J. G. C., & Dias, J. M. G. (2018). Vacinação pública contra o papilomavirus humano no Brasil. Rev Med Minas Gerai. https://doi.org/10.5935/2238-3182.20180004
Silva, R. F., & Engstrom, E. M. (2020). Atenção integral à saúde do adolescente pela Atenção Primária à Saúde no território brasileiro: uma revisão integrativa. Interface - Comunicação, Saúde, Educação, 24, 1–17. https://doi.org/10.1590/INTERFACE.190548
Siu, J. Y. M., Lee, A., & Chan, P. K. S. (2019). Schoolteachers’ experiences of implementing school-based vaccination programs against human papillomavirus in a Chinese community: a qualitative study. BMC Public Health, 19(1). https://doi.org/10.1186/s12889-019-7878-7
Townsend, P. (1987). Conceptualising Poverty. Dynamics of Deprivation. Aldershot: Gower.
Veiga, C. R. P. da, Semprebon, E., Silva, J. L. da, Ferreira, V. L., & Veiga, C. P. da. (2020). Facebook HPV vaccine campaign: insights from Brazil. Human Vaccines & Immunotherapeutics, 16(8), 1824–1834. https://doi.org/10.1080/21645515.2019.1698244
World Health Organization. (n.d.). (2021). Adolescent health. World Health Organization. Retrieved October 5, from https://www.who.int/health-topics/adolescent-health#tab=tab_1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Beatriz Tianeze de Castro; Anna Luzia Pinho Quaresma ; Andressa Oliveira Azevêdo; Lucas Marques da Silva; Camila Silveira Silva Teixeira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
